Gavin MacBeath, Chief Scientific Officer at TScan Therapeutics, Inc. (TCRX), bought 5,000 shares at $6.19 ($31K) on 2021-09-21, disclosed to the SEC on 2021-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.22 | 4,943 | $31K | 98.9% |
| 2 | $6.19 | 57 | $353 | 1.1% |
| Total | $6.22 avg | 5,000 | $31K | 100% |